里程碑制药公司宣布将于2026年2月中旬启动Cardamyst全国销售团队部署

美股速递
Jan 26

里程碑制药公司(Milestone Pharmaceuticals Inc.)近日披露,其针对创新药物Cardamyst的全国销售团队部署计划已正式敲定,将于2026年2月中旬全面启动。这一战略举措标志着公司核心产品商业化进程进入关键阶段,为潜在的市场渗透与营收增长奠定基础。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10